Commit Biologics is a startup based in Denmark, most recent round Seed, 2 tracked investors.
Commit Biologics is a startup founded in 2021 based in Denmark. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
Commit Biologics is a biotechnology company that develops a novel immunotherapy platform called BiCE™, which activates the complement system to selectively kill cancer cells and immune cells involved in autoimmune diseases using bispecific antibodies that bind to the complement protein C1q.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.